Bogart Wealth LLC’s Novavax NVAX Stock Holding History

Bogart Wealth LLC’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19	Hold	2	–	–	﹤0.01%	1983
2026 Q1	$16	Buy	+2	New	+$18	﹤0.01%	1797
2024 Q4	–	Sell	-10	Closed	-$126	–	1362
2024 Q3	$126	Hold	10	–	–	﹤0.01%	1113
2024 Q2	$127	Hold	10	–	–	﹤0.01%	1096
2024 Q1	$48	Hold	10	–	–	﹤0.01%	1062
2023 Q4	$48	Hold	10	–	–	﹤0.01%	1053
2023 Q3	$72	Hold	10	–	–	﹤0.01%	1059
2023 Q2	$74	Hold	10	–	–	﹤0.01%	1033
2023 Q1	$69	Sell	10 -10	-50%	-$92	﹤0.01%	1095
2022 Q4	$206	Buy	20 +5	+33%	+$88	﹤0.01%	962
2022 Q3	$0	Buy	15 +10	+200%	+$433	﹤0.01%	1090
2022 Q2	$0	Sell	5 -5	-50%	-$259	﹤0.01%	949
2022 Q1	$1K	Sell	10 -20	-67%	-$1.78K	﹤0.01%	747
2021 Q4	$4K	Hold	30	–	–	﹤0.01%	587
2021 Q3	$6K	Buy	30 +20	+200%	+$4.41K	﹤0.01%	523
2021 Q2	$2K	Hold	10	–	–	﹤0.01%	604
2021 Q1	$2K	Hold	10	–	–	﹤0.01%	560
2020 Q4	$1K	Buy	+10	New	+$1.06K	﹤0.01%	441

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Bogart Wealth LLC's NVAX Position: Q2 2026 in Review

Bogart Wealth LLC held its Novavax (NVAX) position steady in Q2 2026 at 2 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Bogart Wealth LLC first reported a position in NVAX in Q4 2020 and has held it in 18 quarters since. The position peaked at $6K in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Bogart Wealth LLC held 2 shares of Novavax worth $19 as of Q2 2026.
Bogart Wealth LLC left its Novavax share count unchanged in Q2 2026.
Novavax made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1983 holding.
Bogart Wealth LLC first reported a position in Novavax in Q4 2020 and has held it in 18 quarters since.
Bogart Wealth LLC's Novavax position peaked at $6K in Q3 2021.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.